CpG-island methylation in aging and cancer - PubMed (original) (raw)

Review

CpG-island methylation in aging and cancer

J P Issa. Curr Top Microbiol Immunol. 2000.

No abstract available

PubMed Disclaimer

Similar articles

• Tumour-specific distribution of BRCA1 promoter region methylation supports a pathogenetic role in breast and ovarian cancer.
  Bianco T, Chenevix-Trench G, Walsh DC, Cooper JE, Dobrovic A. Bianco T, et al. Carcinogenesis. 2000 Feb;21(2):147-51. doi: 10.1093/carcin/21.2.147. Carcinogenesis. 2000. PMID: 10657950
• Aberrant methylation and silencing of ARHI, an imprinted tumor suppressor gene in which the function is lost in breast cancers.
  Yuan J, Luo RZ, Fujii S, Wang L, Hu W, Andreeff M, Pan Y, Kadota M, Oshimura M, Sahin AA, Issa JP, Bast RC Jr, Yu Y. Yuan J, et al. Cancer Res. 2003 Jul 15;63(14):4174-80. Cancer Res. 2003. PMID: 12874023
• DNA Methylation Patterns Separate Senescence from Transformation Potential and Indicate Cancer Risk.
  Xie W, Kagiampakis I, Pan L, Zhang YW, Murphy L, Tao Y, Kong X, Kang B, Xia L, Carvalho FLF, Sen S, Chiu Yen RW, Zahnow CA, Ahuja N, Baylin SB, Easwaran H. Xie W, et al. Cancer Cell. 2018 Feb 12;33(2):309-321.e5. doi: 10.1016/j.ccell.2018.01.008. Cancer Cell. 2018. PMID: 29438699 Free PMC article.
• CpG island methylator phenotypes in aging and cancer.
  Toyota M, Issa JP. Toyota M, et al. Semin Cancer Biol. 1999 Oct;9(5):349-57. doi: 10.1006/scbi.1999.0135. Semin Cancer Biol. 1999. PMID: 10547343 Review.
• Alterations of DNA methylation in hematologic malignancies.
  Rush LJ, Plass C. Rush LJ, et al. Cancer Lett. 2002 Nov 8;185(1):1-12. doi: 10.1016/s0304-3835(02)00288-4. Cancer Lett. 2002. PMID: 12142073 Review.

Cited by

• The role of aberrant promoter hypermethylation of DACT1 in bladder urothelial carcinoma.
  Cheng H, Deng Z, Wang Z, Zhang W, Su J. Cheng H, et al. J Biomed Res. 2012 Sep;26(5):319-24. doi: 10.7555/JBR.26.20110099. Epub 2011 Apr 12. J Biomed Res. 2012. PMID: 23554767 Free PMC article.
• Global DNA hypomethylation in peripheral blood leukocytes as a biomarker for cancer risk: a meta-analysis.
  Woo HD, Kim J. Woo HD, et al. PLoS One. 2012;7(4):e34615. doi: 10.1371/journal.pone.0034615. Epub 2012 Apr 11. PLoS One. 2012. PMID: 22509334 Free PMC article.
• Techniques used in studies of epigenome dysregulation due to aberrant DNA methylation: an emphasis on fetal-based adult diseases.
  Ho SM, Tang WY. Ho SM, et al. Reprod Toxicol. 2007 Apr-May;23(3):267-82. doi: 10.1016/j.reprotox.2007.01.004. Epub 2007 Jan 19. Reprod Toxicol. 2007. PMID: 17317097 Free PMC article. Review.
• Quantitative, high-resolution epigenetic profiling of CpG loci identifies associations with cord blood plasma homocysteine and birth weight in humans.
  Fryer AA, Emes RD, Ismail KM, Haworth KE, Mein C, Carroll WD, Farrell WE. Fryer AA, et al. Epigenetics. 2011 Jan;6(1):86-94. doi: 10.4161/epi.6.1.13392. Epub 2011 Jan 1. Epigenetics. 2011. PMID: 20864804 Free PMC article.
• Association between cyclin D1 polymorphism with CpG island promoter methylation status of tumor suppressor genes in gastric cancer.
  Tahara T, Shibata T, Nakamura M, Yamashita H, Yoshioka D, Okubo M, Yonemura J, Maeda Y, Maruyama N, Kamano T, Kamiya Y, Fujita H, Nakagawa Y, Nagasaka M, Iwata M, Hirata I, Arisawa T. Tahara T, et al. Dig Dis Sci. 2010 Dec;55(12):3449-57. doi: 10.1007/s10620-010-1206-5. Epub 2010 Apr 16. Dig Dis Sci. 2010. PMID: 20397048

Publication types

MeSH terms

LinkOut - more resources

• Full Text Sources

  • Springer

• Other Literature Sources

  • The Lens - Patent Citations Database

• Medical

  • MedlinePlus Health Information